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Sjögren’s syndrome (SS) is a chronic systemic autoimmune disease that affects
predominately salivary and lacrimal glands. SS can occur alone or in combination with
another autoimmune disease like systemic lupus erythematosus (SLE). Here we report
that TLR7 signaling drives the development of SS since TLR8-deficient (TLR8ko) mice that
develop lupus due to increased TLR7 signaling by dendritic cells, also develop an age-
dependent secondary pathology similar to associated SS. The SS phenotype in TLR8ko
mice is manifested by sialadenitis, increased anti-SSA and anti-SSB autoantibody
production, immune complex deposition and increased cytokine production in salivary
glands, as well as lung inflammation. Moreover, ectopic lymphoid structures characterized
by B/T aggregates, formation of high endothelial venules and the presence of dendritic
cells are formed in the salivary glands of TLR8ko mice. Interestingly, all these phenotypes
are abrogated in double TLR7/8-deficient mice, suggesting that the SS phenotype in
TLR8-deficient mice is TLR7-dependent. In addition, evaluation of TLR7 and inflammatory
markers in the salivary glands of primary SS patients revealed significantly increased TLR7
expression levels compared to healthy individuals, that were positively correlated to TNF,
LT-a,CXCL13 andCXCR5 expression. These findings establish an important role of TLR7
signaling for local and systemic SS disease manifestations, and inhibition of such will likely
have therapeutic value.
Keywords: Sjögren’s syndrome (SS), TLR7, innate immunity, autoimmunity, TLR8-deficient mice, dendritic cells,
transgenic miceINTRODUCTION
Sjögren’s syndrome (SS) is a chronic systemic autoimmune disease characterized by infiltration and
destruction of exocrine glands, predominantly the salivary and lacrimal glands, that leads to
xerostomia (dry mouth) and keratoconjunctivitis sicca (dry eyes) (1). Apart from glandular
symptoms, fatigue and arthralgia are also common, and systemic complications involving the
respiratory, vascular, neurological and nervous systems, affects one third of patients (2). The
prevalence of the disease is about 0.5% in the general population and it is most commonly seen in
middle-aged women, with a considerable sex bias of 9:1 female to male ratio (1). SS can develop asorg May 2021 | Volume 12 | Article 6760101
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with another autoimmune disease, like systemic lupus
erythematosus (SLE), rheumatoid arthritis or systemic
sclerosis, termed “secondary” or “associated” SS (3). The
etiology of SS is multifactorial, where genetic, epigenetic,
hormonal and environmental factors are thought to
interact (4, 5). Among the environmental factors, microbial
infections, particularly by viruses such as Epstein-Barr virus,
cytomegalovirus, hepatitis C virus and retroviruses are considered
as an important trigger for SS (4).
Little is known about the mechanisms that support SS
etiology and the corresponding early and sustained molecular
events in SS disease. At the same time, growing evidence points
towards a significant role of innate immune detection of nucleic
acids by TLRs in the development of autoimmunity (6). Nucleic
acids of exogenous (microbial) or endogenous (nuclear or
mitochondrial) origin are detected by nucleic acid receptors in
the cytoplasm and induce pro-inflammatory cytokines and type I
IFN production. Human endosomal TLRs consist of TLR3 that
senses double-stranded RNA (7), TLR7 and TLR8 that detect
single-stranded RNA and TLR9 that recognizes DNA containing
unmethylated CG dinucleotides (8). Interestingly, the
corresponding murine TLRs detect similar ligands, with the
exception of murine TLR8 that is unable to sense ssRNA due
to the lack of five amino acids in its extracellular part (9). Despite
the fact that murine TLR8 does not detect ssRNA, we
demonstrated previously that it plays an important biological
role in restraining TLR7 signaling on dendritic cells, but not on B
cells or macrophages (10, 11). Similarly, human TLR8 can also
restrain mouse TLR7, as it was reported in transgenic mice that
express human TLR8, whereas high expression of human TLR8
led to severe inflammation and premature death, while low
expression caused increased susceptibility to collagen-induced
arthritis (12). Although the endosomal localization isolate TLR3,
7, 8 and 9 away from self-nucleic acids in the extracellular space,
still self-RNA or -DNA can become a potent trigger of cell
activation when transported into TLR-containing endosomes
and can lead to sterile inflammation and autoimmunity (6).
Particularly, endosomal TLR7 has been shown to play a critical
role in the development of SLE, while its role in SS remains
poorly understood. Indeed, increased TLR7 signaling has been
associated with SLE development both in humans and mice,
while in various SLE mouse models depletion of TLR7 led to the
amelioration or even prevention of lupus disease (10, 11, 13–18).
TLR ligation leads to the recruitment of the adaptor molecule
MyD88, except of TLR3 that recruits TRIF, and triggers the
activation of transcription factors, which induce the release of
pro-inflammatory cytokines, type I IFNs and other
proinflammatory mediators that contribute to the development
of autoimmunity (19). MyD88 is ubiquitously expressed by all
immune cells and is required for TLR signaling, except of TLR3.
Interestingly, in the NOD.B10sn-H2b/j (NOD.B10) mouse
model of primary SS, deletion of the MyD88 signaling pathway
leads to attenuated SS disease, suggesting that MyD88 is a crucial
mediator of local and systemic SS disease manifestations (20).Frontiers in Immunology | www.frontiersin.org 2Salivary gland dysfunction in SS is attributed to both
a systemic and a localized autoimmune response within
the salivary gland. The systemic autoimmunity in SS is
highlighted by the detection of antibodies, mainly towards
ribonucleoproteinic complexes such as anti-SSA (anti-Ro) and
anti-SSB (anti-La), which serve as markers for clinical diagnosis
(21). The presence of organized ectopic lymphoid structures
(ELS) that contain infiltrating T and B lymphocytes, dendritic
cells (DCs) and macrophages, within the salivary glands are
indicative of a localized immune response in the disease (1). The
morphology of these ELS ranges from aggregates of lymphocytes,
to well organized tertiary lymphoid organs (TLOs) containing
distinct T and B cells zones, DCs, high endothelial venules
(HEV), lymphatic vessels and B cell follicles with germinal
centers (22). The development of ELS in organs that are
specifically targeted by autoimmune disease suggest that they
function as local sites of antigen presentation by DCs and areas
of lymphocyte activation (22). Several cytokines/chemokines and
their corresponding receptors are involved in the formation of
TLOs, including lymphotoxins (LTa3 and LTa1b2), TNF,
CXCL13, CCL19 and CCL21 (23).
The importance of TLR7 signaling in the development of SLE
is well established, however, its role in SS development is poorly
understood. Moreover, SLE and SS are two closely related
autoimmune diseases and a possible connection between the
mechanisms that lead to SLE and SS has been suggested based on
some common features of the two diseases, including
epidemiological characteristics, clinical manifestations,
serological profiles and genetic risk factors (24). Despite the
differences in the immune system between humans and mice,
murine models constitute an advanced tool for modelling
pathogenic mechanisms of complex diseases like SLE or SS
(25). In this context we have shown previously that TLR8-
deficiency in C57BL/6 mice leads to lupus development due to
increased TLR7 expression and signaling by DCs, and that this
phenotype can be exacerbated under high fat diet conditions due
to the additional increase of TLR7 signaling (10, 11, 26). Here we
demonstrate a critical role for TLR7 signaling in the pathogenesis
of associated SS in TLR8-deficient mice that is characterized by
sialadenitis, increased SSA and SSB autoantibody production,
immune complex deposition, increased cytokine production and
development of ELS in salivary glands, as well as lung
inflammation. Interestingly, in human salivary gland tissue of
SS patients we found increased TLR7 expression that was
positively correlated to TNF, LT-a, CXCL13 and CXCR5
expression levels.MATERIALS AND METHODS
Mice
TLR8ko and double TLR7/8ko mice were generated as described
previously (10, 27). Both TLR-deficient mouse lines were
backcrossed on the C57BL/6 background for more than 10
generations. In order to normalize the microbiota between theMay 2021 | Volume 12 | Article 676010
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TLR8 genes are both located in the X chromosome, female age-
matched TLR-deficient mice and their respectiveWT control mice
were derived by mating littermate TLR-heterozygous female mice
with WT or TLR-deficient male mice (e.g., TLR8X+X− x TLR8X+Y,
or TLR8X−Y). Mice were allowed to consume water and pellet shew
ad libitum. Mice were housed under specific pathogen-free
conditions at the Center d’Immunologie de Marseille-Luminy.
All animal studies were performed in accordance with institutional
guidelines for care and use of laboratory animals and with
protocols approved by the Comité National de Réflexion
Ethique sur l’Expérimentation Animale.
Histology and Immunofluorescence
For histopathology studies, salivary gland and lung tissues were
collected. SG were fixed in AntigenFix (MMFRance,
Francheville, France) for 2h, washed with phosphate buffer,
dehydrated in 30% sucrose in PBS for an overnight, embedded
in OCT-compound and frozen in liquid nitrogen. Sections were
cut on cryostat at 10 mm, thaw-mounted on gelatinized slides and
stained with H&E or processed for immunofluorescence
staining. Antibodies that were used were: hamster anti-CD11c
(clone N418, BD Biosciences) followed by anti-hamster IgG/
AF488 (polyclonal, Jackson Immunoresearch), rat anti-CD3
(Biorad) followed by anti-rat IgG/AF594, rat anti-CD45R/
AF647 (clone RA3-6B2, BD Biosciences), rat anti-HEV
marker/AF488 (clone Meca-79, eBioscience), donkey anti-IgG/
AF488 (Invitrogen), and anti-IgM/AF633 (Invitrogen). Lungs
were fixed in formalin, embedded in paraffin and stained with
H&E. Slides were scanned using Pannoramic Scan (3D Histech)
and Image J was used to measure the lymphocytic infiltration
present in the tissue. This was quantified by the division of the
area of infiltration by the total tissue area examined.
Serological Analysis
For detection of autoantibodies against SSA, SSB and RNA on
serum samples, Nunc plates were precoated with 1.0 µg/ml Ro
(SSA), 1.0 µg/ml La (SSB) antigen (Arotec Diagnostics), or 5µg/ml
RNA (purified from mouse liver) for an overnight. Plates were
incubated for 1h with blocking buffer (PBS, 1% BSA), mouse
sera were applied at a dilution 1:100 and the assay was developed
using anti-mouse IgG (H+L)-horseradish peroxidase
(Southern Biotech).
RNA Isolation and Q-PCR
Total RNA from murine SMG was isolated with TRizol reagent.
RNA was reverse transcribed with Superscript II reverse
transcriptase (Invitrogen) and Q-PCR was performed as
described previously (10). For human minor SG, RNA
extraction, cDNA synthesis and Q-PCR were done as
described previously (28). The primers used for Q-PCR are
listed in Supplementary Table 1.
Subjects
Minor salivary gland (MSG) biopsies were obtained from 40 SS
patients and 8 sicca controls at the Department of
Pathophysiology, School of Medicine at the National andFrontiers in Immunology | www.frontiersin.org 3Kapodistrian University of Athens, Athens, Greece as a routine
part of the diagnostic evaluation for SS. A written informed
consent was received from participants prior collection of the
samples. None of the SS patients were complicated by
lymphoma. The biopsies were immediately frozen at -80°C.
Focus score was determined for each MSG biopsy sample, as
previously described (29). SS patients and sicca controls were
females with mean age ± SD: 59 ± 16 and 53 ± 8 years old,
respectively. SS patients were classified according to the 2016
ACR criteria (30). The sicca control group included individuals
complaining of sicca symptoms, not fulfilling the SS criteria.
Statistics
Data analyses and representations were performed with Prism 8
(GraphPad Software). Data are presented as mean ± SD unless
otherwise specified. For group comparisons, statistical analysis
gathering more than 2 groups were performed using Kruskal-Wallis
followed by Wilcoxon rank sum tests and correction for multiple
comparisons using the Benjamini-Hochberg method (Figures 1, 2),
or one-way ANOVA followed by Tukey test (Figures 3, 4
and Supplementary Figure 1E). For 2-group comparisons,
statistical analyses were performed using Mann-Whitney U test
(Figures 5A, B, and Supplementary Figures 1A–D). The Pearson
correlation coefficient was applied to determine the dependence of
2 variables. Differences were considered statistically significant when
*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.RESULTS
SS Phenotype in TLR8ko Mice
Is TLR7-Dependent
Since current data suggest that TLR7 might be involved in SS we
examined the phenotype of TLR8ko mice, which as we reported
previously, by the age of 8 months develop spontaneous SLE-like
disease due to increased TLR7 signaling by DCs (10, 11). Both
female and male TLR8ko mice at the age of 8- and 14-months
had splenomegaly compared to WT controls (Figure 1A and
Supplementary Figure 1A), while TLR7/8ko mice did not
(Figure 1A). On the contrary, no consistent salivary gland
weight to body weight variation was noted among WT and
TLR8ko mice for both genders (data not shown). Since, exocrine
gland inflammation is a hallmark of SS patients, we examined
whether 8- and 14-months old TLR8ko female mice with clinical
disease of SLE show signs of sialadenitis compared to age- and
gender-matchedWT and TLR7/8ko mice. We found that both 8-
and 14-months old female TLR8ko mice had statistically
increased submandibular gland (SMG) inflammation compared
to WT or TLR7/8ko mice (Figures 1B, C). Moreover, we also
evaluated SMG inflammation in 8-month old male TLR8ko
mice, and found statistically increased inflammation compared
to their WT controls (Supplementary Figures 1B, C). Notably,
8-months old female TLR8ko (5.8 ± 2.9) andWT (1.2 ± 1.5) mice
had 2- and 8-times higher score of SMG inflammation compared
to male TLR8ko (2.1 ± 1.8) and WT (0.15 ± 0.2) mice,
respectively. Thus, exacerbated SG inflammation in TLR8koMay 2021 | Volume 12 | Article 676010
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in males.
Next, we assessed serum levels of IgG autoantibodies against
SSA, SSB and RNA in mouse sera. We found statisticallyFrontiers in Immunology | www.frontiersin.org 4increased anti-SSA, anti-SSB and anti-RNA antibodies in 8-
and 14-months-old female TLR8ko compared to aged-matched
WT and TLR7/8ko controls (Figure 1D). Fourteen-months old





FIGURE 1 | TLR8ko mice develop TLR7-dependent SS. Spleens and salivary gland were harvested from 8- and 14-months-old TLR8ko, TLR7/8ko and WT female
mice. (A) Spleen weight of TLR8ko, TLR7/8ko and WT mice. (B) Salivary gland tissues were sectioned and representative areas of H&E stained sections are shown.
Panels in upper row magnification x1, panels in lower row magnification x4 of the black frames indicated in the upper row panels. Black arrows denote lymphocytic
infiltration. (C) Pathological scores of SG were evaluated and results are expressed as mean +/- SD of total foci area versus SG area x 100. Scale bars: 0.5 mm.
(D) Levels of anti-SSA, anti-SSB and anti-RNA antibodies in sera of 8- and 14-months-old TLR8ko, TLR7/8ko and WT female mice were evaluated by ELISA.
(E) Representative microphotographs of immunofluorescence detection of IgG and IgM in SG sections from TLR8ko, TLR7/8ko and WT female mice. Scale bars:
100 mm. Statistical analysis was done by Kruskal-Wallis followed by Wilcoxon rank sum tests and correction for multiple comparisons using the Benjamini-Hochberg
method. In (A, B, D) each time point represents the value of one mouse and horizontal bars denote mean. In (A–D) pooled data from 4 independent experiments,
and in (E) data are representative of 2 independent experiments with 3-5 mice per genotype. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.May 2021 | Volume 12 | Article 676010
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however, the difference did not reach statistical significance
(Figure 1D). Notably, the levels of anti-SSA and anti-RNA
were statistically increased in female WT versus TLR7/8ko
mice at the age of 8-months old and 14-months old,
respectively (Figure 1D). Similarly, 8-months old male
TLR8ko mice had statistically increased levels of anti-SSA and
anti-RNA autoantibodies compared to WT mice, whereas the
anti-SSB levels were also increased, but the difference did not
reach statistical significance (Supplementary Figure 1D). To
determine the possibility that direct deposition of antibodies is
taking place within the SG, the presence of IgG and IgM was
analysed by direct immunofluorescence. We observed increased
IgG and IgM deposition in SMG of female TLR8ko versus WT
mice, especially at 14-month old mice, while in TLR7/8ko mice
IgG and IgM depositions were almost undetectable (Figure 1E).
Thus, these results demonstrate that TLR8ko mice have
increased serum levels of anti-SSA, anti-SSB and anti-RNA
autoantibodies and deposition of IgG and IgM in the SMG
compared to WT mice, and these phenomena are TLR7-
dependent, since they are absent in double TLR7/8ko mice.
We noticed that the observed SS phenotype was generally
more profound in female than in male mice and we wondered
whether this difference could be attributed to TLR7 levels.Frontiers in Immunology | www.frontiersin.org 5Therefore, we evaluated TLR7 mRNA levels in the SMG of
female and male WT and TLR8ko mice by quantitative PCR.
Tlr7 expression was almost 2-times higher in female than in male
TLR8ko SMG (Supplementary Figure 1E). Based on these
overall observations we decided to focus the rest of our studies
in female mice.
Lung Inflammation in TLR8ko Mice Is
TLR7-Dependent
Since lung involvement is common in SS patients (31), we next
investigated whether TLR8ko mice develop lung inflammation.
Lungs were harvested from 8- and 14-months old female
TLR8ko, TLR7/8ko and WT mice and evaluated for
inflammation by H&E staining. Lungs from TLR8ko mice
showed lymphocytic infiltration, predominately in the peri-
bronchial regions. Both 8- and 14-months old female TLR8ko
mice had statistically significant higher lung inflammation
compared to WT mice (Figures 2A–C). However, TLR7/8ko
mice did not show any signs of lung inflammation (Figures 2A–C).
Additionally, 14-months oldWTmice also showed small areas of
lymphocytic infiltrates and had statistically significant higher
lung inflammation compared to age-matched TLR7/8ko mice
(Figures 2B, C). Hence, TLR8ko mice develop TLR7-dependent
lung inflammation.A B
C
FIGURE 2 | Lung inflammation in TLR8ko mice. Lung inflammation scoring at (A) 8-months and (B) 14 months old WT, TLR8ko and TLR7/8ko mice.
(C) Representative micrographs of lungs from 8- and 14-months old WT, TLR8ko and TLR7/8ko mice. H&E-stained lung sections show inflammatory foci (arrows).
Scale bars: 0.5 mm. Statistical analysis was done by Kruskal-Wallis followed by Wilcoxon rank sum tests and correction for multiple comparisons using the
Benjamini-Hochberg method. Data are representative of 2 independent experiments combined. *P < 0.05, ***P < 0.001.May 2021 | Volume 12 | Article 676010
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In SS patients, salivary ELS develop in 30-40% of patients (32,
33), thus we examined the presence of ELS features within the
inflammatory foci, such as T/B cells segregation, as well as the
presence of DCs and HEV. In female TLR8ko mice we observed
T and B cell lymphocytic aggregates, in close proximity with
DCs, while in WT mice these structures were predominantly
absent (Figure 3A). No ELS were observed within the SMG of
TLR7/8ko mice (data not shown). Moreover, immunofluorescent
staining for HEV with MECA-79 revealed that some of the
inflammatory foci in TLR8ko SMGs contained HEV that were
colocalized within the areas of T and DC aggregates (Figure 3B).
In order to further validate the increased presence of HEV in
TLR8ko mice, we also evaluated the mRNA expression of theFrontiers in Immunology | www.frontiersin.org 6HEV markers glycosylation-dependent cell adhesion molecule-1
(Glycam1) and glucosaminyl (N-Acetyl) transferase 1 (Gcnt1) by
Q-PCR in SGM derived fromWT and TLR8ko mice. We noticed
a statistically increased expression of both HEV markers in
TLR8ko versus WT mice (Figure 3C). Thus, 8-months old
TLR8ko mice develop ELS that contain B and T cells, DCs and
HEV in their SG inflammatory foci, while these structures are
generally absent in age and sex matched WT mice.
Increased Expression of Cytokines
and B Cell Markers in TLR8ko SMGs
Is TLR7-Driven
To investigate if the increased SG inflammation in TLR8ko mice
was accompanied by local expression of cytokines and B cellA
B
C
FIGURE 3 | Identification of TLS in the infiltrates of TLR8ko SMG. Immunofluorescent microscopic analysis of lymphocyte infiltrates in SMG of 8-months old TLR8ko
mice. Frozen sections were stained with fluorescent labelled (A) CD3 for T cells (red), B220 for B cells (violet) and CD11c for DCs (green) and (B) Meca79 for HEV
(green), CD11c for DCs (red) and CD3 for T cells (violet). Scale bars: 100 mm; magnification x20. (C) Expression of the HEV markers Glycam1 and Gcnt1 was
evaluated in the SMG of WT, TLR8ko and TLR7/8ko mice by Q-PCR. Plots represent mean ± SD of triplicates, with n=5-6 mice combined per genotype. Statistical
analysis was done by one-way ANOVA followed by Tukey’s multiple-comparison test. (A–C) Results are representative of two independent experiments with 5-6
mice per genotype and per experiment. **P < 0.01, ****P < 0.0001.May 2021 | Volume 12 | Article 676010
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old female WT, TLR8ko and TLR7/8 ko mice and evaluated by
quantitative PCR. The expression of the inflammatory cytokines
Il-6, Tnf and Lt-awas significantly elevated in 8- and 14-months old
female TLR8ko mice compared to age and sex matched WT
controls, while TLR7/8ko mice showed normal levels of all three
cytokines (Figure 4A). We also evaluated Ifnb, but the expression
levels were very low to drive reliable conclusions (data not shown).
In addition, since B cells contribute in the pathogenesis of SS (34),
we also evaluated the expression of the B cells markers CXCL13,
CXCR5 and B cell activation factor (BAFF). CXCL13 directs B-cell
chemotaxis and is elevated in several autoimmune diseases,
including SS (35), CXCR5 is a chemokine receptor mainly
expressed on B cells and a subset of T cells, called follicular B
helper T cells, and binds the chemotactic ligand CXCL13 (36), while
BAFF is central to the cross talk between early activation of the
immune system and the stimulation of autoreactive B cells (37).
The Cxcl13 and Cxcr5mRNA levels were considerably increased in
the SMGs of 8- and 14-months old female TLR8ko mice versusWT
or TLR7/8 controls (Figure 4B). Regarding Baff, although thereFrontiers in Immunology | www.frontiersin.org 7were no obvious differences at 8-months old mice, there was
significantly increased Baff expression levels in 14-months old
TLR8ko SMGs compared to WT or TLR7/8ko mice (Figure 4B).
Notably, 14-months oldWTmice also showed statistically increased
Cxcl13 and Cxcr5 expression levels compared to TLR7/8ko mice
(Figure 4B). Thus, TLR7-signaling is the mediator for the observed
increased levels of Il-6, Tnf and Lt-a cytokines and B cells markers
Cxcl13, Cxcr5 and Baff in TLR8ko SMG.
Increased Cytokine and Chemokine
Expression in the SG of SS Patients
Is Correlated to TLR7 Expression
To gain insights into the potential association of TLR7 in the
development of SS in humans, we evaluated the expression of
TLR7 in the salivary glands of 40 female patients with primary SS
and 11 female age matched sicca controls using quantitative
PCR. We found that TLR7 expression was significantly higher in
the salivary glands of SS patients compared to sicca controls
(Figure 5A). We also assessed the expression of TNF, LT-a,
CXCL13 and CXCR5, all of which were found to be increased inA B
FIGURE 4 | Increased levels of cytokines and B cell markers in TLR8ko SMG. Expression of (A) Il-6, Tnf and Lt-a and (B) Cxcl13, Cxcr5 and Baff mRNA levels were
evaluated in the SMG of 8- and 14-months old female WT, TLR8ko and TLR7/8ko mice by Q-PCR. Plots represent mean ± SD of triplicates, with n=5-6 mice
combined per genotype. Statistical analysis was done by one-way ANOVA followed by Tukey’s multiple-comparison test. Data are representative of at least two
independent experiments. *P <0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.May 2021 | Volume 12 | Article 676010
Wang et al. Increased TLR7 Prompts Sjögren’s Syndromethe SMGs of TLR8ko mice that develop signs of SS. All four genes
were higher expressed in SS patients than in sicca controls,
whereas the difference was statistically significant for CXCL13
and CXCR5, but not for TNF and LT-a (Figure 5B). Next,
correlation analyses were performed to investigate the
relationship between TLR7 expression and TNF, LT-a,
CXCL13 and CXCR5 levels. TLR7 mRNA levels were positively
correlated with TNF (r=0.744, p<0.0001), LT-a (r=0.679,
p<0.0019), CXCL13 (r=0.875, p<0.001) and CXCR5 (r=0.923,
p<0.0001) expression, while no correlations were found in sicca
controls (Figure 5C). Hence, SS patients show increased levels of
cytokines and B cell markers that are positively correlated to
TLR7 expression.Frontiers in Immunology | www.frontiersin.org 8DISCUSSION
The importance of TLR signaling is well established in many
autoimmune diseases, especially the implication of TLR7 in SLE
both in humans and in mice. However, the role of TLRs in SS is
poorly understood. We demonstrated previously that in vivo
TLR8 restrains TLR7 on DCs, and that TLR8ko mice on the
C57BL/6 background develop spontaneous lupus due to
increased TLR7 signaling by DCs, while TLR8ko B cells or
macrophages retain normal TLR7 signaling (10, 11, 26). Here
we show that TLR8ko mice also develop SS that is characterized
by sialadenitis, lung inflammation, increased SSA and SSB
autoantibody production, and within the SG deposition of IgGA
B
C
FIGURE 5 | Increased TLR7 expression in the SG of the SS patients is positively correlated with TNF, LT-a, CXCL13 and CXCR5 expression levels. RNA was
extracted from the salivary glands of female patients with primary SS and age matched sicca donors and the expression levels of (A) TLR7 and (B) TNF, LT-a,
CXCL13 and CXCR5 were evaluated by Q-PCR. Each point represents one individual and horizontal lines correspond to mean. Number of individuals (n) per group
are denoted in parenthesis. Statistical analysis was done by non-parametric Mann-Whitney test. (C) Correlation analysis was performed to investigate the expression
relationship between TLR7 and TNF, LT-a, CXCL13 and CXCR5 expression levels, and were expressed as Pearson correlation coefficient (r). Pearson’s correlation
and P values are listed at the top of each mini-plot. Each point represents one individual. For SS patients (n=19-40) and for sicca controls (n=7-11). *P < 0.05,
**P < 0.01, ****P < 0.0001, ns, non statistical.May 2021 | Volume 12 | Article 676010
Wang et al. Increased TLR7 Prompts Sjögren’s Syndromeand IgM immune complex, increased cytokine and chemokine
production and presence of ELS. Interestingly, all these
phenotypes are absent in double TLR7/8ko mice indicating
that the associated SS phenotype in TLR8ko mice is TLR7-
dependent. In addition, by studying minor SG of female
patients with primary SS we found that TLR7, CXCL13 and
CXCR5 mRNA expression levels were significantly higher in
diseased versus sicca controls, and that TLR7 expression was
positively correlated to TNF, LT-a, CXCL13 and CXCR5
expression levels. Thus, we describe a new mouse model of SS
in which disease development is TLR7-driven and provide
evidence that TLR7 is also implicated in the SG inflammation
of SS patients. Therefore, blocking TLR7 signaling might have
therapeutic utility for the progression and treatment of SS.
Previous studies have suggested an association of TLR7 with
the pathophysiology of SS (38). TLR7 stimulated B cells from
primary SS patients secrete increased amounts of various cytokines
and show upregulated levels of surface markers (39). Type I IFN
positive plasmacytoid DCs (pDCs) and monocytes isolated from
peripheral blood mononuclear cells of primary SS patients show
upregulation of TLR7, as well as, the downstream signaling
molecules MyD88 and IRF7, and the DC maturation marker,
radical S-adenosyl methionine domain containing 2 (RSAD2) (40).
Moreover, monocyte-derived DCs from patients with primary SS
exhibit enhanced maturation upon stimulation with the TLR7/8
agonist (CL097) compared to healthy controls (41). In accordance,
our previous studies shown that both conventional DCs (cDCs)
and pDCs from TLR8-deficient mice show increased expression of
TLR7 that is accompanied by increased signaling upon stimulation
with TLR7 agonists, while in TLR8komacrophages or B cells TLR7
signaling is normal (26). Moreover, we demonstrated here that
TLR7 signaling is pivotal for the development of associated SS in
TLR8ko mice since double TLR7/8ko mice were protected, and
that sialadenitis was more profound in female than in male mice.
This sex bias could be associated with increased TLR7 expression
in TLR8ko female versus male mice. Indeed, our present studies
revealed increased TLR7 mRNA levels in the SMG of TLR8ko
female versus male mice. Moreover, studies in our lab have also
demonstrated increased protein levels of TLR7 in the pDCs and
DCs of TLR8ko female versus TLR8ko male mice (unpublished
data). Actually, a striking aspect of SS and SLE is the sexual bias,
with women being affected 10 times more than men. While this
female bias remains poorly understood, the X chromosome dose
effect could be suspected to account for the disease. In this aspect,
the TLR7 gene is located on the X chromosome and may govern
gender differences in the development of systemic autoimmune
diseases. In fact, recent independent studies on SS patients showed
an increased prevalence of 47, XXX trisomy in women, as well as
Klinefelter’s syndrome (47, XXY) in men (42, 43). Moreover, rare
X chromosome abnormalities have been found among patients
with either SS or SLE (44). In accordance, our present studies with
female primary SS patients revealed an increased expression of
TLR7 within the minor SGs that was positively associated with
TNF, LT-a, CXCL13 and CXCR5 expression levels. Taken
together, these data demonstrate that TLR7 is likely to play an
important role in the chronic inflammatory environment observed
in SS disease.Frontiers in Immunology | www.frontiersin.org 9ELS often develop in target organs of autoimmune diseases,
including the salivary glands of patients with SS or animal models
of SS (45). These structures are characterized by clusters of B and
T lymphocytes, development of HEV and differentiation of
follicular DC networks, while their formation and maintenance
dependents on the ectopic expression of lymphotoxins and
lymphoid chemokines such as CXCL13. We showed here that
TLR8ko mice develop ELS within their SMG that consist of B and
T cell clusters, and presence of DCs. Moreover, they show
increased differentiation of HEV, consistently with enhanced
expression of the HEV markers Glycam1 and Gcnt1 in the
SMG of TLR8ko mice compared to WT or TLR7/8ko mice.
Hence, TLR7 signaling is pivotal for the formation of ELS and
HEV in the SMG of TLR8ko mice. In line with our findings, it has
been reported that MyD88 signaling is central in the formation of
HEV in the ELS of the SMG and the development of autoimmune
sialadenitis in two mouse models of associated SS, the lupus prone
B6/lpr and the diabetic NOD mice (46).
CXCL13 is considered as a biomarker in SS, since 74% of
patients with SS display elevated CXCL13 in sera, saliva or both.
Serum CXCL13 levels correlate with the extent of salivary gland
inflammation and lymphoid organization (35, 47). Moreover, the
CXCL13-CXCR5 axis plays a central role in regulating B cell
aggregation and organization, and local expression of CXCL13
within the SG has been previously associated with the degree of
cellular organization of ELS in patients with SS and animal
models of the disease (47, 48). Here, we demonstrated that the
formation of ELS in the SMGs of TLR8ko mice is accompanied
by significantly increased levels of Cxcl13 and Cxcr5 within the
SMG compared to WT mice. In contrast, the expression levels of
Cxcl13 and Cxcr5 were minimal and the formation of ELS were
absent within the SMG of double TLR7/8ko mice, suggesting that
TLR7 signaling is vital in controlling CXCL13 expression.
Moreover, we also demonstrated that in primary SS patients
the increased expression of TLR7 within the minor SGs was
positively associated with increased CXCL13 and CXCR5
expression levels. Remarkably, and in agreement with our
findings CXCL13 production by human monocytes upon
stimulation with ssRNA requires TLR7 activation of pDCs and
secretion of type I IFNs (49).
B cells have an important role in SS, as detection of
autoantibodies against SSA or SSB is one of the diagnostic
criteria found in a majority of patients. Here, we found
increased levels of SSA and SSB autoantibodies, as well as
autoantibodies against RNA, in TLR8ko mice, while this
increase was absent in double TLR7/8ko mice. Moreover,
BAFF regulates B lymphocyte proliferation and survival, and
has an important role in autoimmunity since BAFF transgenic
mice develop lupus-like disease, and with increasing age they also
develop a second pathology reminiscent to SS (50). In humans,
SS also correlates with elevated levels of circulating BAFF, as well
as a dramatic upregulation of BAFF expression in inflamed SGs.
In accordance, in SMGs of 14-months old TLR8ko mice we
found statistically increased Baff expression levels compared to
WT mice. In contrast, TLR7/8ko mice had normal levels of Baff
expression within their SMGs, indicating that the increased Baff
expression in TLR8ko mice is TLR7-dependent. Noteworthy,May 2021 | Volume 12 | Article 676010
Wang et al. Increased TLR7 Prompts Sjögren’s SyndromeBAFF is the target of the only currently approved biological
therapy for SLE, which also provide therapeutic benefits in
patients with pSS without major side effects (51).
In summary, we identified a novel role for TLR7 signaling in
driving associated SS development in mice. We also provide
evidence for elevated TLR7 expression within the SG of primary
SS patients and a positive correlation to inflammatory markers
(CXCL13, CXCR5, TNF and LT-a), which have been previously
reported to contribute to SS disease and that were also elevated in
the SMG of TLR8ko mice. Moreover, the TLR8ko mice is a new
animal model for spontaneously associated SS that is TLR7-
dependent, has many similarities with the observations reported
in patients with SS, and as such is expected to facilitate further
studies to clarify deeper the pathophysiology of SS. This work has
important implications for therapeutics, since blocking the TLR7
pathway might prove to be a novel strategy for preventing and/or
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